AndrewLFeldmanMD

PubMed

• 637 citations
  Enterocolitis in patients with cancer after antibody blockade of cytotoxic T-lymphocyte-associated antigen 4
  Kimberly E. Beck, Joseph A. Blansfield, Khoi Q. Tran, Andrew L. Feldman, Michael S. Hughes
  Journal of Clinical Oncology. 2006-05-20
• 254 citations
  Analysis of factors associated with outcome in patients with malignant peritoneal mesothelioma undergoing surgical debulking and intraperitoneal chemotherapy
  Andrew L. Feldman, Steven K. Libutti, James F. Pingpank, David L. Bartlett, Tatiana Beresnev
  Journal of Clinical Oncology. 2003-12-15
• 79 citations
  Proteomic Analysis of Apoptotic Pathways Reveals Prognostic Factors in Follicular Lymphoma
  Christian Gulmann, Virginia Espina, Emanuel F. Petricoin, Dan L. Longo, Mariarita Santi
  Clinical Cancer Research. 2005-08-15

Journal Articles

• Publisher Correction: Molecular Subtypes of Diffuse Large B Cell Lymphoma Are Associated with Distinct Pathogenic Mechanisms and Outcomes  
  Thomas M Habermann, Scott J Rodig, Rameen Beroukhim, Jeremiah A Wala, Andrew L Feldman, Todd R Golub, Margaret A Shipp, Nature

Abstracts/Posters

• Malignant T-Cells and Normal Intratumoral T-Cells Have Similar Expression of Immune Checkpoint Molecules in Angioimmunoblastic T-Cell Lymphoma
  Andrew L. Feldman, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Genomic Analysis of R2CHOP-Treated DLBCL Reveals a High-Risk Population Driven By Inflammatory Pathways
  Andrew L. Feldman, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Prevalence and the Impact of Hypogammaglobulinemia in Newly Diagnosed, Untreated Diffuse Large B Cell Lymphoma
  Andrew L. Feldman, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Vulnerable Elders Survey-13 (VES-13) Predicts 1-Year Mortality Risk in Newly Diagnosed Non-Hodgkin Lymphoma (NHL)
  Andrew L. Feldman, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Intrafollicular CD4+ T-Cells As an Independent Predictor of Early Clinical Failure in Newly Diagnosed Follicular Lymphoma
  Andrew L. Feldman, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• A Phase II Study of Nivolumab in Patients with Relapsed or Refractory Peripheral T-Cell Lymphoma
  Andrew L. Feldman, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• Utility and Patterns of Use of PET/CT and Bone Marrow Biopsy for Staging in Non-Hodgkin Lymphoma in the Clinical Setting: A Retrospective Analysis Using the LEO Database
  Andrew L. Feldman, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Join now to see all

Lectures

• The Lymphoma Epidemiology of Outcomes (LEO) Cohort Study Reflects the Demographics and Subtypes of Patients Diagnosed with Non-Hodgkin Lymphoma in the United States 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018